CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,410
- in 2 filings
Net −$5,410. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-08 | Lettmann Jason Director | Sale | −1,531 | $33.80 | $52K | 2,230,720 |
| 2021-12-08 | Lettmann Jason Director | Sale | −208 | $33.80 | $7K | 304,131 |
| 2021-12-08 | LSV Associates, LLC 10% owner | Sale | −35,836 | $33.23 | $1.2M | 2,232,251 |
| 2021-12-08 | LSV Associates, LLC 10% owner | Sale | −4,883 | $33.23 | $162K | 304,339 |
| 2021-12-08 | LSV Associates, LLC 10% owner | Sale | −1,531 | $33.80 | $52K | 2,230,720 |
| 2021-12-08 | LSV Associates, LLC 10% owner | Sale | −208 | $33.80 | $7K | 304,131 |
| 2021-11-22 | Randolph Sophia Chief Medical Officer | Option exercise | +30,000 | $4.08 | $122K | 179,428 |
| 2021-11-22 | Randolph Sophia Chief Medical Officer | Sale | −14,884 | $36.77 | $547K | 164,544 |
| 2021-11-22 | Randolph Sophia Chief Medical Officer | Option exercise · Stock Option (right to buy) | −30,000 | 107,906 | ||
| 2021-10-19 | Pons Jaume President & CEO | Sale | −14,471 | $54.17 | $784K | 446,827 |
| 2021-10-19 | Pons Jaume President & CEO | Sale | −2,229 | $55.12 | $123K | 444,598 |
| 2021-10-19 | Pons Jaume President & CEO | Sale | −14,471 | $54.17 | $784K | 446,827 |
| 2021-10-19 | Pons Jaume President & CEO | Sale | −2,229 | $55.12 | $123K | 444,598 |
| 2021-10-18 | GARCIA PETER S Chief Financial Officer | Option exercise | +7,229 | $4.08 | $29K | 16,560 |
| 2021-10-18 | GARCIA PETER S Chief Financial Officer | Sale | −2,851 | $54.33 | $155K | 13,709 |
| 2021-10-18 | GARCIA PETER S Chief Financial Officer | Sale | −1,903 | $55.15 | $105K | 11,806 |
| 2021-10-18 | GARCIA PETER S Chief Financial Officer | Sale | −1,437 | $56.09 | $81K | 10,369 |
| 2021-10-18 | GARCIA PETER S Chief Financial Officer | Sale | −411 | $57.54 | $24K | 9,958 |
| 2021-10-18 | GARCIA PETER S Chief Financial Officer | Sale | −438 | $58.30 | $26K | 9,520 |
| 2021-10-18 | GARCIA PETER S Chief Financial Officer | Sale | −189 | $59.06 | $11K | 9,331 |
Page 12 of 22 · 432 trades